Home›People›Alexander Bailey
AB

Alexander Bailey

Chief Executive Officer and director at OptoVista Holdings.

ExecutiveDirector
Updated Nov 16, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Alexander Bailey

Alexander Bailey is a chief executive officer and director at OptoVista Holdings.

Alexander Bailey first appears on SEC filings in 2024.

Experience

This experience comes from Alexander Bailey's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alexander Bailey in the role, so the role may have started earlier or lasted longer.

OptoVista Holdings, LLC Current
Co-Founder, CEO (2023 – Present)
Director
2023 – Present · Washington, DC
Develops gene therapies for people with rare diseases.
California Institute for Regenerative Medicine (CIRM) Current
Grants Working Group Reviewer
2017 – Present
Digitalis Commons
Expert in Residence (XIR)
2024
Bailey Consulting LLC
Founder and Principal
2023 – 2024
REGENXBIO Inc.
Head, Early Program and Portfolio Development
2016 – 2023
FDA
Team Leader, Pharmacology / Toxicology (OTP/CBER)
2010 – 2016
Fred Hutchinson Cancer Research Center
Post-doctoral Research Fellow
2009 – 2010
University of Virginia School of Medicine
Post-Doctoral Research Fellow
2008 – 2009

Key Colleagues at Startups

The people Alexander Bailey works with at each company, as listed on that company's latest Form D.

OptoVista Holdings, LLC · Form D, Sep 25, 2026
MR
Matthew Rosini
Chief Financial and Administration Officer
KP
SO
CO
Christina Ohnsman
Chief Medical Officer

Sources

  1. SECOptoVista Holdings, LLC Form D, filed Sep 25, 2026